Moreover, given the temporal evolution from SCLC-A to SCLC-N, observed in both the MYC-driven SCLC model11 and the KDM6A-inactivation mouse model13, it is possible that these observed intra-tumoral heterogeneities are snapshots of cells at different stages of subtype switching. This evidence concerns the gene KDM6A and small cell lung carcinoma.